RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 13.38
0.00 (0.00%)
Mar 6, 2026, 8:00 AM GMT
RUA Life Sciences Revenue
In the fiscal year ending September 30, 2025, RUA Life Sciences had annual revenue of 4.46M GBP with 8.42% growth. RUA Life Sciences had revenue of 2.59M in the half year ending March 31, 2025, with 140.84% growth.
Revenue
4.46M
Revenue Growth
+74.47%
P/S Ratio
1.86
Revenue / Employee
75.58K
Employees
59
Market Cap
8.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 4.46M | 346.34K | 8.42% |
| Mar 31, 2025 | 4.11M | 1.92M | 87.72% |
| Mar 31, 2024 | 2.19M | 12.00K | 0.55% |
| Mar 31, 2023 | 2.18M | 554.00K | 34.09% |
| Mar 31, 2022 | 1.63M | 97.00K | 6.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| GENinCode | 2.91M |
| Verici Dx | 1.40M |